Article
Navigating diagnostic shifts: A comparative review of the WHO 5th edition and ICC 2022 classifications of myeloid neoplasms.
Human pathology - 1 Mar 2026
Koorse Germans Sharon, Weinberg Olga K
Abstract excerpt
The near-simultaneous publication of the World Health Organization (WHO) 5th Edition classification of hematolymphoid tumors (WHO-HAEM5) and the International Consensus Classification (ICC) in 2022 represents a pivotal moment in the taxonomy of myeloid neoplasms. Both systems emphasize integration of morphology, cytogenetics, and molecular genetics, yet they diverge in several clinically meaningful areas,...
Topics
- Humans
- Myelodysplastic Syndromes
- World Health Organization
- Leukemia, Myeloid, Acute
- Prognosis
- Hematologic Neoplasms
- Mutation
- Predictive Value of Tests
